VYOME HOLDINGS, INC. Impairment of Intangible Assets, Finite-lived
VYOME HOLDINGS, INC. (HIND) reported Impairment of Intangible Assets, Finite-lived of $777.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2023-11-09
- VYOME HOLDINGS, INC. impairment of intangible assets, finite-lived for the quarter ending 2023-09-30 was $777.00K, a 89.54% decline year-over-year.
- VYOME HOLDINGS, INC. impairment of intangible assets, finite-lived for the quarter ending 2022-09-30 was $7.43M.
- VYOME HOLDINGS, INC. impairment of intangible assets, finite-lived for fiscal 2021 was $7.20M.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|
| 2023-09-30 | $777.00K 10-Q · filed 2023-11-09 | $777.00K 10-Q · filed 2023-11-09 | |
| 2022-09-30 | $7.43M 10-Q · filed 2023-11-09 | $7.43M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $7.20M 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |